Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 320 participants.

Also called NCT05677100

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 320 participants (planned count) (from the registry)
Sponsor
Procyrion (from the registry)
Registry
  • NCT NCT05677100
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Hungary (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05677100. Randomized; no masking; primary purpose treatment. Start 2023-08-23 (actual); primary completion 2028-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Acronym
DRAIN-HF
Condition
Heart Failure
Condition
Cardiorenal Syndrome
Condition
Cardio-Renal Syndrome
Condition
ADHF
Condition
Heart Failure, Systolic
Condition
Heart Failure, Diastolic
Condition
Heart Failure; With Decompensation
Condition
Heart Failure, Congestive
Intervention (Device)
Aortix System
Lead sponsor
Procyrion (class: industry)

Record details

Record id
cardio:ct-nct05677100
Content hash
94aa936298fb66421f2a7ccca4f3cf9eadfbd1d7cab97faf5e0329729b423e99